Skip to main content
Log in

Assessment of acute thrombolysis with newly developed myocardial single-photon emission computed tomographic techniques

  • Editorials
  • Published:
Journal of Nuclear Cardiology Aims and scope

Conclusion

Freeze imaging allows simultaneous evaluation of the area at risk and salvaged myocardium. It is also useful for determining the indication for emergency reperfusion therapy from the extent and degree of the defect at the time of administration before thrombolysis or primary angioplasty. In contrast, memory imaging provides diagnostic information on various tracers, which, dependent on the tracer, is different from that of myocardial perfusion. Thus detailed properties of the infarcted myocardium may be assessed from the memory image.

These new tracers provide the same information on the whole, although each has slightly different characteristics. It remains unsolved which tracer is the most useful for the evaluation of reperfusion therapy or the outcome of the therapy. However, at least one of these imagings should be incorporated actively by nuclear cardiologists.

Nuclear cardiology has excellent characteristics that allow imaging of perfusion, necrosis, metabolism, and receptors, which are different from those of echocardiography, x-ray computed tomography, and magnetic resonance imaging, and a low assessment of new clinical conditions that will appear as new therapeutic methods are developed. When used appropriately, these procedures can significantly improve the use of reperfusion therapy by defining indications in particular patient subgroups, observing the course of therapeutic efficacy, and evaluating porttherapy prognosis and other outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Califf RM, Topol EJ, Gersh BJ. From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. J Am Coll Cardiol 1989;14:1382–8.

    Article  PubMed  CAS  Google Scholar 

  2. Califf RM, Harrelson-Woodief L, Topol EJ. Left ventricular ejection fraction may not be useful as an end point for thrombolytic therapy: comparative trials. Circulation 1990;82:1847–53.

    PubMed  CAS  Google Scholar 

  3. Feiring AJ, Johnson MR, Kioschos JM, et al. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 1987;75:980–7.

    PubMed  CAS  Google Scholar 

  4. Nishimura T, Uehara T, Hayashida K, et al. Newly developed myocardial imaging by using single photon emission computed tomography (SPECT). Jpn Circ J 1990;54:328–32.

    PubMed  CAS  Google Scholar 

  5. Beller GA. Noninvasive assessment of myocardial salvage after coronary reperfusion: a perpetual quest of nuclear cardiology. J Am Coll Cardiol 1989;14:874–6.

    PubMed  CAS  Google Scholar 

  6. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxy isobutylisonitrile. Circulation 1990;82:1424–37.

    PubMed  CAS  Google Scholar 

  7. Gibbons R, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277–86.

    PubMed  CAS  Google Scholar 

  8. Wackers FJ, Gibbons RJ, Verani MS, et al. Serial quantitative planar technetium-99m-isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989;14:861–73.

    PubMed  CAS  Google Scholar 

  9. Pelikka PA, Behrenbeck T, Verani MS, et al. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropylisonitrile imaging following reperfusion therapy of myocardial infarction. J Nucl Med 1990;31:1269–75.

    Google Scholar 

  10. Santoro G, Bisi G, Sciagra R, et al. Single photon emission computed tomography with technetium-99m-hexakis-2-methoxy-2-methylpropylisonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol 1990;15:301–14.

    Article  PubMed  CAS  Google Scholar 

  11. Christian TF, Behrenbeck T, Gersh BJ, Gibbons RJ. Relation of left ventricular volume and function over one year following acute myocardial infarction to infarct size determined by Tc-9m sestamibi. Am J Cardiol 1991;68:21–6.

    Article  PubMed  CAS  Google Scholar 

  12. Christian TF, Gibbons RJ, Gersh BJ. The effect of infarct location on myocardial salvage assessed by Tc-99m-isonitrile. J Am Coll Cardiol 1991;17:1303–8.

    Article  PubMed  CAS  Google Scholar 

  13. Gibbons RJ, Christian TF, Hoptenspirger M, Hodge DO, Bailey KR. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 1994;24:616–23.

    PubMed  CAS  Google Scholar 

  14. Ogawa K, Harata Y, Ichihara T, et al. A practical method for position-dependent Compton-scatter correction in single photon emission CT. IEEE Trans Med Imaging 1991;10:408–12.

    Article  PubMed  CAS  Google Scholar 

  15. Krause K, Kasper W, Zeiher A, et al. Relation of technetium-99m pyrophosphate accumulation to time interval after onset of acute myocardial infarction as assessed by a tomographic acquisition technique. Am J Cardiol 1991;68:1575–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hashimoto T, Kambara H, Fudo T, et al. Significance of technetium-99m/thallium-201/overlap on simultaneous dual emission computed tomography in acute myocardial infarction. Am J Cardiol 1988;61:1181–6.

    Article  PubMed  CAS  Google Scholar 

  17. Beller GA, Khaw BA, Haber E, et al. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts: comparison with technetium-99m stannous pyrophosphate. Circulation 1977;55:74–8.

    PubMed  CAS  Google Scholar 

  18. Khaw BA, Strauss HW, Moore R, et al. Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. J Nucl Med 1987;28:76–82.

    PubMed  CAS  Google Scholar 

  19. Johnson LL, Seldin DW, Keller AM, et al. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk. Circulation 1990;81:37–45.

    PubMed  CAS  Google Scholar 

  20. Martin GV, Cerqueira MD, Cadwell JH, et al. Fluoromisonidazole: a metabolic marker of myocyte hypoxia. Circ Res 1990;67:240–4.

    PubMed  CAS  Google Scholar 

  21. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-labeled nitroimidazole (BMS 181321) in normoxic, hypoxic, ischemic and stunned myocardium. J Nucl Med 1994;35:1371–6.

    PubMed  CAS  Google Scholar 

  22. Knapp FF, Goodman MM, Callahan AP, et al. Radioiodinated 15-(σ-iodophenyl)-3,3-dimethyl-pentadecanoic acid: a useful new agent to evaluate myocardial fatty acid uptake. J Nucl Med 1986;24:521–31.

    Google Scholar 

  23. Nishimura T, Sago M, Kihara K, et al. Fatty acid myocardial imaging using 123I-β-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1989;15:341–5.

    Article  PubMed  CAS  Google Scholar 

  24. Nishimura T, Uehara T, Shimonagata T, Nagata S, Haze K. Clinical results with β-methyl-p-(123I)iodophenyl pentadecanoic acid: single-photon emission computed tomography in cardiac disease. J Nucl Cardiol 1994;1:S65–71.

    Article  Google Scholar 

  25. Lutz T, Dougan H, Riherd T, Vo CV, Lyster DM. 123I-iodobenzyl glucosamines: glucose analogues for heart imaging. J Label Comp Radiopharm 1993;33:327–44.

    Article  CAS  Google Scholar 

  26. Minardo JP, Tuli MM, Mock BH, et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988;78:1008–19.

    PubMed  CAS  Google Scholar 

  27. Nishimura T, Sago M, Oka H, et al. Serial assessment of denervated but viable myocardium following acute myocardial infarction in dogs using 123I-MIBG and thallium SPECT. Eur J Nucl Med 1992;189:25–9.

    Google Scholar 

  28. Lekakis J, Antoniou A, Vassilopoulos N, et al. I-123 metaiodobenzylguanidine-thallium-201 mismatch following myocardial infarction. Clin Cardiol 1994;17:21–5.

    Article  PubMed  CAS  Google Scholar 

  29. Stanton MS, Tuli MM, Radtke LN, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 123I-metaiodobenzylguanidine. J Am Coll Cardiol 1988;14:1519–26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishimura, T. Assessment of acute thrombolysis with newly developed myocardial single-photon emission computed tomographic techniques. J Nucl Cardiol 2, 163–166 (1995). https://doi.org/10.1016/S1071-3581(95)80029-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(95)80029-8

Navigation